Placental organoids offer powerful tools to advance diagnostics and therapies for pregnancy complications including preeclampsia and fetal growth restriction. However, most current models rely on animal-derived materials and heterogenous cell sources. Developing human-based physiologically relevant organoid models is essential to understand disease phenotypes and improve clinical care for high-risk pregnancies.
Nature Reviews Bioengineering.
2026;4(4):288-290. doi: 10.1038/s44222-026-00409-7
Keywords
Library Collection(s)